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0.05). The concentration of p55 was 7.3 pg/L, IQR 13.8 that local TNF-a may contribute to the regulation of cell prolifpg/L, in urine samples from a group of preschool children eration at the uteroplacental unit; DNA synthesis of trophoblasts (1 mo < age < 5 y) and 6.9 pg/L, IQR 2.9 yg/L, in urine is inhibited by TNF-a (9, 10). However, the detection of TNF-a samples from children in a higher age group (5 y < age < at the fetoplacental unit is somewhat surprising because it is well 10 y). The concentration of the 75-kD TNF-a receptor in known that TNF-a mediates effects that might be considered urine did not differ significantly between the different age threatening to the well-being of the fetus; i.e. TNF-a is probably groups studied. The elevated p55 serum levels of pregnant an important mediator in transplantation rejection (1 1, 12), and women and neonates are suggestive of a pregnancy-asso-animal studies suggest that placental injury may be caused by ciated release of soluble receptors. The high concentration TNF-a (1 3). Furthermore, TNF-a is apparently involved in of p55 in neonatal urine may reflect a postpartum elimi-premature pregnancy termination and abortion in mice (14, 15) . nation of soluble receptors shed during pregnancy. Further In humans, elevated TNF-a levels in amniotic fluid are associstudies are needed to determine the origin and physiologic ated with infections and premature onset of parturition (16, 17) . implications of the soluble TNF-a receptors in pregnancy.
The biological effects of TNF-a are mediated through its (Pediatr Res 33: [82] [83] [84] [85] [86] [87] 1993) interaction with high-affinity receptors on target cells (18, 19) . There are two molecular species of TNFR (20) (21) (22) (23) (24) (25) , the 55-kD TNFR protein, p55, and the 75-kD TNFR protein, p75. Each Abbreviations species also exists as soluble molecules (26, 27 ) that are probably shed from cells expressing TNFR on their surfaces (28), a phe-TNF, tumor necrosis factor nomenon that has been demonstrated in activated neutrophils TNFR, tumor necrosis factor receptor (29). The soluble TNFR specifically bind TNF-a (26, 30) . Thus, the extracellular domain of the TNFR with a molec-due to their ability to compete with the cell surface receptors for ular mass of 55 kD TNF-a, soluble TNFR may function as inhibitors of TNF-(I. the domain of the TNFR with a bioactivity (26, 30, 31) . Accordingly, secretion of specific, soluble ular mass of 75 kD membrane receptors could serve as a mechanism for regulating R/p55, the ratio between the concentration of soluble p55 cytokine activity in viva (32, 33), (%/L) and the concentration of protein in urine ( l d L ) Previously, we have reported elevated levels of p5 j in urine the between the concentration of "luble samples from pregnant women (34), suggesting that shedding of (pg/L) and the concentration of protein in urine (pdL) soluble TNFR may be a mechanism of regulating TNF-a activity maternal organism or whether the fetus also is exposed to the 82 shed TNFR. Fetal urine influences the composition of amniotic fluid (34), and we have previously reported that amniotic fluid contains high levels of soluble TNFR (35) . Accordingly, this study included an examination of the first-voided urine from newborns for the presence of TNFR. In addition, levels of p55 in neonatal serum samples were assessed. Maternal and neonatal serum samples contained elevated levels of soluble p55, as did first-voided urine from newborn babies. Thus, the data presented in this article, together with previous observations ( 3 9 , suggest that a pregnancy-associated shedding of p55 takes place. The present study suggests that the soluble receptors are distributed throughout the maternal as well as the fetal organism.
MATERIALS AND METHODS
Serum samples. Blood was obtained by venipuncture from 28 pregnant women and from 10 nonpregnant women at fertile age. All pregnant women were in spontaneous labor, and all pregnancies were considered normal. Peripheral blood was also obtained by venipuncture from 15 newborns at the Neonatal Department during the first 24 h of life. The blood was allowed to clot at room temperature for 1-3 h; after centrifugation, the serum was stored at -20°C until assayed.
Urine collection. To determine whether soluble TNFR might be released from the fetus via urine, first-voided urine was collected from 70 healthy, newborn babies (46 boys, 23 girls) delivered at term. We have previously shown that there are no systematic changes in urine TNFR concentration during a 24-h period (35) , and therefore the urine samples were collected whenever obtained during the first 24-h period after delivery.
To study the TNFR elimination in the perinatal period, the concentration of soluble TNFR in urine samples from nine healthy newborns was determined on d 1, 3, and 5 after delivery. All babies were born at term, and the urine samples were collected at any time during the indicated 24 h.
First morning urine samples from 40 children at different ages were collected to obtain information about urine elimination of soluble TNFR during childhood. All children were patients at the Children's Department at the Regional Hospital during the last 4 mo of 1991. Urine samples included in the study were randomly taken from those samples brought to the laboratory for routine examination. The diagnoses of the children included in this part of the study are given in Table I . The children were divided into three groups, each group determined by the age of the children: group A (n = 8), 1 d % age 5 1 mo; group B (n = 22), 1 mo < age 5 5 y; and group C (n = lo), 5 y < age 510 y (Table I) . After collection, all urine samples were frozen at -20°C until assayed.
Informed consent was obtained from the women/mothers to collect the materials included in the study. Peripheral blood was taken from newborn babies at the Neonatal Department. For ethical reasons, neonatal serum could be obtained only if venipuncture was to be performed for other medical reasons. The study was approved by the Local Committee for Human Research.
Immunoassay for detection of soluble TNFR in urine. Immunoassays have been established for the detection of p55 and p75 in urine as described by Liabakk et al. (36) . The immunoassays are based on pairs of MAb directed against different epitopes of p55 and p75 (21) . Briefly, immunoplates were coated with MAb against either p55 (htr MAb) or p75 (utr MAb), samples were added, and bound TNFR were detected by using B htr MAb or B utr MAb, respectively (2 1). Bound B MAb were detected with a streptavidin-peroxidase complex (2 1). Absorbance was measured at 492 nm.
Urine samples were passed through an Amicon filter (Amicon Corp., Danvers, MA) with a 10-kD cutoff before addition to the immunoplates. This filtration caused a 10-fold concentration of urine samples. *Children under study were patients from Children's Department. First-morning urine was randomly obtained, and the urine samples were examined for p55, p75, and protein. The numbers represent the measured level in urine from each individual. ND, not detected; RDS, respiratory distress syndrome; BPD, bronchopulmonary dysplasia. The detection limit of the TNFR immunoassay was 0.6 pg/L.
The specificity of the immunoassays was controlled by preincubation of the concentrated urine with 10 mg/L of different cytokines (human TNF-a, human TNF-P, and human interferon-~). Only TNF-a, and to a lesser degree TNF-@, inhibited the TNFR signals from urine samples (36) . These observations suggest that the immunoassays are specific for unoccupied TNFR in urine.
Immunoassay for detection of p55 in serum. The signals obtained when serum samples were added to the immunoassay described above were not inhibited when rTNF-a was added, indicating a nonspecific interaction. Thus, modifications of the immunoassay were done to assay serum samples. Immunoplates (Maxisorp, Nunc, Roskilde, Denmark) were coated with the p55-specific MAb IV 4E, which detects an epitope on p55 outside the binding of TNF-a (Lien E, Liabakk N-B, Espevik T, manuscript in preparation). The MAb was diluted in PBS, and 100 pL of antibody were added to each well in the concentration 10 mg/ L. Immunoplates were incubated for 12 h at 4°C. After blocking with 0.5% BSA (RIA grade, Sigma Chemical Co., St. Louis, MO) 8 4 AUSTGUI ,EN ET AL. for 1 h at 37"C, wells were washed three times with PBS containing 0.1 % Tween 20 (Sigma Chemical Co.) and 100 pL of different dilutions of serum were added and incubated for 12 h at 4°C. Because MAb IV 4E and TNF-a bind to different epitopes of p55, bound receptor was detected by adding 50 pg/L B rTNF-a (TNF-a-Biotin, Boehringer Mannheim, Germany) in PBS with 0.1 % Tween 20 and 2% FCS (Gibco, Biocult, Glasgow, Scotland) to the wells. Immunoplates were incubated for 1 h at 37°C in humidity. After washing, bound B rTNF-a was detected with streptavidin-biotin-peroxydase complex using o-phenylenediamine as substrate (Dakopatts, Glostrup, Denmark). The reaction was stopped with 2NH2S04. The absorbance was measured at 492 nm with a Titertek Multiscan Plus MKII (Flow, Boggio, Switzerland). The binding of B rTNF-a was abolished when an excess (5 mg/L) of rTNF was added to the assay, showing that the binding of B rTNF-a was not caused by an unspecific binding of biotin to the immunoplates.
The absorbance values obtained in the p55 and p75 assays for urine and serum samples were compared to the absorbance of reference standards of p55 and p75 in recombinant forms (F. Hoffmann-La Roche, Basel, Switzerland). Results are expressed in pg/L. The detection limit for the immunoassay applied for analysis of urine samples was 0.6 pg/L concentrated urine. The detection limit for the assay with MAb IV 4E was 0.3 pg/L serum.
Protein concentration. To determine whether the levels of TNFR in urine were caused by changes reflected in urine protein concentration, protein concentration in all urine samples was determined. The protein concentration was determined by Biorad protein assay (Biorad Laboratories, Miinich, Germany), the analysis being performed after the urine had been passed through the Amicon filter.
Statistical analysis. The distribution of TNFR in urine samples collected from the different groups of children showed a marked right-side skew with potentially high outliers. The median is therefore used as a measure of central tendency of all variables, and the variability is expressed as the IQR. TNFR concentrations in urine from different groups were compared by Kruskal-Wallis one-way analysis of variance. The Mann-Whitney test was used for comparison between pairs of groups.
p values less than 0.05 were considered statistically significant.
RESULTS
Detection ofp55 in serum from pregnant women and newborn babies. The soluble 55-kD TNFR was detected in sera from all pregnant women in spontaneous labor (Fig. 1) ; the average p55 concentration of the pregnant group was 6.4 pg/L, IQR 7.2 fig /   Fig. 1 . Serum concentrations of the 55-kD TNFR in samples of peripheral blood from pregnant women in spontaneous delivery at term, from newborn babies, and from nonpregnant controls. Each data point represents the measured level in serum from one individual. The receptors were detected in an immunoassay, and the detection limit of the assay is indicated by the dotted line.
L. Serum samples from newborn babies also contained increased levels of p55 (Fig. I) . The average TNFR concentration in serum for the group of newborns was 3.2 fig/L, IQR 0.7 pg/L. No p55 was detected in serum samples from nonpregnant controls (Fig. 1) .
Detection ofp55 and p75 in urinefrom newborn babies. Firstvoided urine from newborns contained both molecular species of the TNFR at high levels ( Table 2 ). The average concentration of p55 was 44.6 pg/L, IQR 96.6 pg/L, and the average concentration of p75 was 64.8 fig/L, IQR 122.9 pg/L, in urine samples from healthy babies delivered at term. The urine protein concentration in the newborn group was 1767 mg/L, IQR 1426 mg/L. There were no significant differences between the concentrations of p55, p75, or protein in urine samples from girls and boys (Table 2) .
Changes in urine TNFR concentration during the perinatal period. Urine samples from a group of nine healthy babies, obtained on d 1, 3, and 5 after delivery, were examined to study the TNFR elimination postpartum. The concentration of p55 in urine samples on d 5 after delivery was significantly lower ( p < 0.05) than that on d 1 and on d 3 (Table 3 ). However, the calculated ratios (R/p55) between the concentrations of p55 and urine protein concentrations did not differ significantly between the days studied. Thus, we conclude that the observed changes in p55 concentration may partly be caused by 1) the physiological dehydration that usually occurs during the first days postpartum; and 2) the increased fluid intake, and thus secondarily, urine dilution, which takes place approximately 5 d after delivery (37). The urine levels of p75 did not differ significantly on the days compared (Table 3) ; neither did the urine protein concentration (Table 3) or the ratio (R/p75) between the concentration of p75 and urine protein (numbers not shown) differ.
Changes in urine TNFR concentration during childhood. The concentration of p.55 in urine was highest in the neonatal period when different age groups of children were compared (Fig. 2) . Urine samples from children in group A (see Materials and Methods) contained significantly ( p < 0.0 1) higher levels of p55 (50.2 pg/L, IQR 45.8 pg/L) than those of group B (7.3 pg/L, IQR 13.8 pg/L) and group C (6.9 pg/L, IQR 2.9 pg/L) (Fig. 2) . 
